TABLE 3.
Maternal and infant health outcomes of the included VeCaS‐population of women in the COVID‐19 pandemic period (2020) versus the prepandemic period (2019), total n = 5913
| 2019 | 2020 | Statistical differences between 2019–2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Primiparous | Multiparous | Total | Primiparous | Multiparous | Total | Primiparous | Multiparous | |
| n = 2963 | n = 1317 | n = 1646 | n = 2950 | n = 1319 | n = 1631 | ||||
| 100% | 44% | 56% | 100% | 45% | 55% | ||||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | P‐value * | P‐value * | P‐value * | |
| Maternal health outcomes | |||||||||
| Episiotomy a | |||||||||
| No | 2101 (82.1) | 748 (67.6) | 1353 (93.1) | 2149 (84.4) | 780 (70.5) | 1369 (95.0) | 0.03 | 0.141 | 0.032 |
| Yes | 458 (17.9) | 358 (32.4) | 100 (6.9) | 398 (15.6) | 326 (29.5) | 72 (5.0) | |||
| 3rd/4th degree tear a | |||||||||
| No | 2489 (97.2) | 1064 (96.1) | 1425 (98.1) | 2464 (96.7) | 1047 (94.7) | 1417 (98.3) | 0.311 | 0.141 | 0.596 |
| Yes | 71 (2.8) | 43 (3.9) | 28 (1.9) | 83 (3.3) | 59 (5.3) | 24 (1.7) | |||
| Blood loss after delivery in ml | |||||||||
| ≤499 | 2167 (76.5) | 894 (71.7) | 1273 (80.4) | 2155 (77.0) | 877 (71.0) | 1278 (81.8) | 0.816 | 0.167 | 0.443 |
| 500–999 | 574 (20.3) | 308 (24.7) | 266 (16.8) | 549 (19.6) | 299 (24.2) | 250 (16.0) | |||
| 1000–1999 | 61 (2.2) | 29 (2.3) | 32 (2.0) | 68 (2.4) | 47 (3.8) | 21 (1.3) | |||
| ≥2000 | 29 (1.0) | 16 (1.3) | 13 (0.8) | 26 (0.9) | 12 (1.0) | 14 (0.9) | |||
| Missing | 132 | 70 | 62 | 152 | 84 | 68 | |||
| Infant health outcomes | |||||||||
| Gestation at birth | |||||||||
| Preterm (<37 weeks) | 137 (4.6) | 84 (6.4) | 53 (3.2) | 124 (4.2) | 88 (6.7) | 36 (2.2) | |||
| Extremely preterm (< 28 weeks) | 5 (0.2) | 4 (0.3) | 1 (0.1) | 3 (0.1) | 2 (0.2) | 1 (0.1) | 0.431 | 0.760 | 0.075 |
| Very preterm (28–31 + 6) | 12 (0.4) | 5 (0.4) | 7 (0.4) | 19 (0.6) | 14 (1.1) | 5 (0.3) | |||
| Moderate to late preterm (32–36 + 6) | 120 (4.0) | 75 (5.7) | 45 (2.7) | 102 (3.5) | 72 (5.5) | 30 (1.8) | |||
| Term (≥37 weeks) | 2826 (95.4) | 1233 (93.6) | 1593 (96.8) | 2826 (95.8) | 1231 (93.3) | 1595 (97.8) | |||
| Term (37–41 + 6) | 2779 (93.8) | 1206 (91.6) | 1573 (95.6) | 2787 (94.5) | 1205 (91.4) | 1582 (97.0) | |||
| Post term (≥42 weeks) | 47 (1.6) | 27 (2.1) | 20 (1.2) | 39 (1.3) | 26 (2.0) | 13 (0.8) | |||
| Gender | |||||||||
| Female | 1392 (47.3) | 621 (47.7) | 771 (47.0) | 1396 (47.6) | 622 (47.8) | 774 (47.5) | 0.781 | 0.954 | 0.749 |
| Male | 1552 (52.7) | 682 (52.3) | 870 (53.0) | 1534 (52.4) | 680 (52.2) | 854 (52.5) | |||
| Missing | 19 | 14 | 5 | 20 | 17 | 3 | |||
| Birthweight (percentiles) b | |||||||||
| <p10 | 284 (9.8) | 187 (14.7) | 97 (6.0) | 268 (9.3) | 175 (13.8) | 93 (5.8) | 0.517 | 0.538 | 0.792 |
| ≥p10 | 2611 (90.2) | 1088 (85.3) | 1523 (94.0) | 2611 (90.7) | 1092 (86.2) | 1519 (94.2) | |||
| Missing | 68 | 42 | 26 | 71 | 52 | 19 | |||
| Apgar score after 5 min | |||||||||
| 0–3 | 50 (1.7) | 31 (2.4) | 19 (1.2) | 38 (1.3) | 16 (1.3) | 22 (1.4) | 0.437 | 0.081 | 0.565 |
| 4–6 | 101 (3.5) | 55 (4.3) | 46 (2.8) | 97 (3.4) | 60 (4.7) | 37 (2.3) | |||
| 7–10 | 2753 (94.8) | 1191 (93.3) | 1562 (96.0) | 2750 (95.3) | 1200 (94.0) | 1550 (96.3) | |||
| Missing | 59 | 40 | 19 | 65 | 43 | 22 | |||
| Perinatal mortality (≤28 days postpartum) | |||||||||
| No | 2924 (99.7) | 1291 (99.4) | 1633 (99.9) | 2917 (99.7) | 1297 (99.7) | 1620 (99.8) | 0.641 | 0.246 | 0.409 |
| Yes | 10 (0.3) | 8 (0.6) | 2 (0.1) | 8 (0.3) | 4 (0.3) | 4 (0.2) | |||
| Missing | 29 | 18 | 11 | 25 | 18 | 7 | |||
a
Birthweight in percentiles according to the perined birthweight charts.
b
The maternal outcomes episiotomy and 3rd and 4th degree tears are calculated for vaginal births only (total population n = 2560 (2019) and n = 2547 (2020). * Values in bold indicate statistically significant results
*
Values in bold indicate statistically significant results.